Fischer Medical Ventures Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Ltd. The disclosure is made pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company has intimated the schedule of an Analyst/Institutional Investor Meeting. The details of the meeting are as follows:
- Day/Date: Monday, 7th September, 2026
- Time: 12:30 PM (IST)
- Participants/Mode of Meeting: Institutional investors meet (Virtual)
- Type of Meeting: One to One Meet
The purpose of the meeting is to discuss the business of the company and general information that is already available in the public domain.
The company has stated that this information will also be available on its website at www.fischermv.com.
A note clarifies that this intimation is being made by the company on a voluntary basis, considering that the proposed meeting is a one-to-one meeting.
The letter is signed by Balajigandla, Company Secretary and Compliance Officer, on behalf of Fischer Medical Ventures Limited.